<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Y</submitter><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>83</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12923772</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Mitochondrial dysfunction has been implicated in major depressive disorder (MDD), but reliable, measurable biomarkers remain elusive. As a minimally invasive and quantifiable biomarker, circulating cell-free mitochondrial DNA (ccf-mtDNA) in blood offers potential for objective assessment of mitochondrial stress in MDD. However, evidence linking regarding the association between ccf-mtDNA levels and MDD is limited and inconsistent.&lt;h4>Methods&lt;/h4>We systematically searched eight databases, including PubMed, EMBASE, and major Chinese repositories. Thirteen studies with 1370 participants (837 individuals with MDD and 533 controls) were included per PRISMA guidelines. P-values were synthesized using the Lipták-Stouffer Z-score method. Sensitivity and fail-safe N analyses ass</pubmed_abstract><journal>Translational psychiatry</journal><pubmed_title>Blood circulating cell-free mitochondrial DNA as a potential biomarker for major depressive disorder: a meta-analysis.</pubmed_title><pmcid>PMC12923772</pmcid><funding_grant_id>82301709</funding_grant_id><funding_grant_id>82371524</funding_grant_id><funding_grant_id>81920108018, 82230046</funding_grant_id><pubmed_authors>Zhao M</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Qi X</pubmed_authors><pubmed_authors>Guo W</pubmed_authors><pubmed_authors>Song S</pubmed_authors><pubmed_authors>Wei W</pubmed_authors><pubmed_authors>Meng Y</pubmed_authors><pubmed_authors>Deng W</pubmed_authors><pubmed_authors>Yu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Blood circulating cell-free mitochondrial DNA as a potential biomarker for major depressive disorder: a meta-analysis.</name><description>&lt;h4>Background&lt;/h4>Mitochondrial dysfunction has been implicated in major depressive disorder (MDD), but reliable, measurable biomarkers remain elusive. As a minimally invasive and quantifiable biomarker, circulating cell-free mitochondrial DNA (ccf-mtDNA) in blood offers potential for objective assessment of mitochondrial stress in MDD. However, evidence linking regarding the association between ccf-mtDNA levels and MDD is limited and inconsistent.&lt;h4>Methods&lt;/h4>We systematically searched eight databases, including PubMed, EMBASE, and major Chinese repositories. Thirteen studies with 1370 participants (837 individuals with MDD and 533 controls) were included per PRISMA guidelines. P-values were synthesized using the Lipták-Stouffer Z-score method. Sensitivity and fail-safe N analyses ass</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T14:50:30.505Z</modification><creation>2026-07-09T11:02:23.409Z</creation></dates><accession>S-EPMC12923772</accession><cross_references><pubmed>41651814</pubmed><doi>10.1038/s41398-026-03865-2</doi></cross_references></HashMap>